MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed

Biochemical and Biophysical Research Communications

Volumn 404, Issue 4, 2011, Pages 889-895

  Long, Justin M ^a   Lahiri, Debomoy K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Alzheimer; Amyloid; Dementia; Neurodegeneration; Non coding RNA; Post transcriptional

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MICRORNA; MICRORNA 101; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BIOINFORMATICS; CELL STRAIN HEK293; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM;

3' UNTRANSLATED REGIONS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BINDING SITES; HEK293 CELLS; HELA CELLS; HUMANS; MICRORNAS; PC12 CELLS; RATS; TRANSCRIPTION, GENETIC;

EID: 79151483332     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.053     Document Type: Article

References (47)

1. Thinakaran G., Koo E.H. Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 2008, 283:29615-29619.
2. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
3. Lahiri D.K., Robakis N.K. The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences. Brain Res. Mol. Brain Res. 1991, 9:253-257.
4. Quitschke W.W., Goldgaber D. The amyloid beta-protein precursor promoter. A region essential for transcriptional activity contains a nuclear factor binding domain. J. Biol. Chem. 1992, 267:17362-17368.
5. Pollwein P., Masters C.L., Beyreuther K. The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter. Nucleic Acids Res. 1992, 20:63-68.
6. Lahiri D.K. An region upstream of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells. Brain Res. Mol. Brain Res. 1998, 58:112-122.
7. Vostrov A.A., Quitschke W.W., Vidal F., et al. USF binds to the APB alpha sequence in the promoter of the amyloid beta-protein precursor gene. Nucleic Acids Res. 1995, 23:2734-2741.
8. Vostrov A.A., Quitschke W.W. The zinc finger protein CTCF binds to the APBbeta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation. J. Biol. Chem. 1997, 272:33353-33359.
9. Rogers J.T., Randall J.D., Cahill C.M., et al. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 2002, 277:45518-45528.
10. Zaidi S.H., Malter J.S. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3'-untranslated region. J. Biol. Chem. 1994, 269:24007-24013.
11. Westmark C.J., Malter J.S. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol. 2007, 5:e52.
12. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
13. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
14. Wang W.X., Huang Q., Hu Y., et al. Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter. Acta Neuropathol. 2010, 10.1007/s00401-010-0756-0.
15. Hebert S.S., Horre K., Nicolai L., et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. USA 2008, 105:6415-6420.
16. Wang W.X., Rajeev B.W., Stromberg A.J., et al. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 2008, 28:1213-1223.
17. Nunez-Iglesias J., Liu C.C., Morgan T.E., et al. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One 2010, 5:e8898.
18. Hebert S.S., Horre K., Nicolai L., et al. MicroRNA regulation of Alzheimer's amyloid precursor protein expression. Neurobiol. Dis. 2009, 33:422-428.
19. Patel N., Hoang D., Miller N., et al. MicroRNAs can regulate human APP levels. Mol. Neurodegener. 2008, 3:10.
20. Fan X., Liu Y., Jiang J., et al. MiR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells. Acta Biochim. Biophys. Sin. (Shanghai) 2010, 42:318-324.
21. Liu W., Liu C., Zhu J., et al. MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice. Neurobiol. Aging 2010, 10.1016/j.neurobiolaging.2010.04.034.
22. Smith P., Al Hashimi A., Girard J., et al. In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J. Neurochem. 2011, 116:240-247.
23. Ghosh C., Song W., Lahiri D.K. Efficient DNA transfection in neuronal and astrocytic cell lines. Mol. Biol. Rep. 2000, 27:113-121.
24. Pleasure S.J., Page C., Lee V.M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J. Neurosci. 1992, 12:1802-1815.
25. Bailey J.A., Ge Y.-W., Lahiri D.K. Sensitive detection of reporter gene assay results. Promega Cell Notes 2007, 17:13-15.
26. Hellemans J., Mortier G., De Paepe A., et al. QBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007, 8:R19.
27. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3:1-12.
28. Bailey J.A., Lahiri D.K. A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease. J. Neurochem. 2010, 112:843-853.
29. Friedman R.C., Farh K.K., Burge C.B., et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
30. Krek A., Grun D., Poy M.N., et al. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
31. Kertesz M., Iovino N., Unnerstall U., et al. The role of site accessibility in microRNA target recognition. Nat. Genet. 2007, 39:1278-1284.
32. Betel D., Koppal A., Agius P., et al. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010, 11:R90.
33. J.M. Long, D.K. Lahiri, Testing microRNA as a novel target for Alzheimer disease - miR-101 regulates levels of amyloid precursor protein (APP), Program No. 427.13, Neuroscience Meeting Planner, Society for Neuroscience, Chicago, IL, 2009.
34. Lahiri D.K., Nall C. Promoter activity of the gene encoding the beta-amyloid precursor protein is up-regulated by growth factors, phorbol ester, retinoic acid and interleukin-1. Brain Res. Mol. Brain Res. 1995, 32:233-240.
35. Ruiz-Leon Y., Pascual A. Brain-derived neurotrophic factor stimulates beta-amyloid gene promoter activity by a Ras-dependent/AP-1-independent mechanism in SH-SY5Y neuroblastoma cells. J. Neurochem. 2001, 79:278-285.
36. Maloney B., Ge Y.W., Greig N., et al. Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease. FASEB J. 2004, 18:1288-1290.
37. Mbella E.G., Bertrand S., Huez G., et al. A GG nucleotide sequence of the 3' untranslated region of amyloid precursor protein mRNA plays a key role in the regulation of translation and the binding of proteins. Mol. Cell Biol. 2000, 20:4572-4579.
38. Vilardo E., Barbato C., Ciotti M., et al. MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J. Biol. Chem. 2010, 285:18344-18351.
39. Zaidi S.H., Malter J.S. Nucleolin and heterogeneous nuclear ribonucleoprotein C proteins specifically interact with the 3'-untranslated region of amyloid protein precursor mRNA. J. Biol. Chem. 1995, 270:17292-17298.
40. Varambally S., Cao Q., Mani R.S., et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008, 322:1695-1699.
41. Strillacci A., Griffoni C., Sansone P., et al. MiR-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp. Cell Res. 2009, 315:1439-1447.
42. Wang H.J., Ruan H.J., He X.J., et al. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur. J. Cancer 2010, 46:2295-2303.
43. Li S., Fu H., Wang Y., et al. MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma. Hepatology 2009, 49:1194-1202.
44. Su H., Yang J.R., Xu T., et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 2009, 69:1135-1142.
45. Lee Y., Samaco R.C., Gatchel J.R., et al. MiR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis. Nat. Neurosci. 2008, 11:1137-1139.
46. Long J.M., Lahiri D.K. Novel specific microRNAs in regulating neuronal genes implicated in Alzheimer's disease. Alzheimers Dement. 2010, 6:e13.
47. J.M. Long, D.K. Lahiri, Role of specific microRNAs in regulating neuronal genes implicated in Alzheimer's disease, Program No. 424.1, Neuroscience Meeting Planner, Society for Neuroscience, San Diego, CA, 2010.